# RetroSense Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/retrosense-therapeutics

- Industry: Biotechnology
- Headquarters: Ann Arbor, US
- Total disclosed funding: $12M
- Latest round: Series B (Nov 12, 2015)
- Investors on record: 9

## About

Founded in 2009 and based in Michigan, US, RetroSense Therapeutics, LLC develops gene therapeutics that provides functional vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration.

## Funding rounds

- Series B, Nov 12, 2015, $6M — Blue Water Angels, Santen Pharmaceutical Co., Ltd., RBV Capital, Exsight ventures, 4BIO Capital Partners
- Series A, Jan 8, 2015, $6M — Michigan Economic Development Corporation, Tech Coast Angels, SDL Ventures, Blue Water Angels, Nerveda, Inc.

## Investors

- Michigan Economic Development Corporation — Series A
- Tech Coast Angels — Series A
- SDL Ventures (https://capitalatlas.ai/funds/sdl-ventures) — Series A
- Blue Water Angels — Series A, Series B
- Nerveda, Inc. — Series A
- Santen Pharmaceutical Co., Ltd. — Series B
- RBV Capital — Series B
- Exsight ventures (https://capitalatlas.ai/funds/exsight-ventures) — Series B
- 4BIO Capital Partners (https://capitalatlas.ai/funds/4bio-capital-partners) — Series B